Overview
Aziz Ouarssani practices practicing medicine in Fes, Morocco.
His clinical expertise encompasses Type A Insulin Resistance Syndrome, Acanthosis Nigricans, and Melasma.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Aziz Ouarssani
Is Aziz Ouarssani a top-rated expert for Type A Insulin Resistance Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Aziz Ouarssani is classified as an Experienced expert for Type A Insulin Resistance Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Aziz Ouarssani participate in research or clinical trials?
Yes. Aziz Ouarssani has published 15 articles and abstracts on conditions like Type A Insulin Resistance Syndrome. You can view a list of Aziz Ouarssani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acanthosis NigricansMr. Ouarssani isExperienced. Learn about Acanthosis Nigricans.
- MelasmaMr. Ouarssani isExperienced. Learn about Melasma.
- Type A Insulin Resistance SyndromeMr. Ouarssani isExperienced. Learn about Type A Insulin Resistance Syndrome.